Association of monocyte/HDL-C ratio with SYNTAX scores in patients with stable coronary artery disease

Herz. 2016 Sep;41(6):523-9. doi: 10.1007/s00059-015-4393-1. Epub 2016 Jan 11.

Abstract

Purpose: The aim of this study was to investigate the relationship between monocyte count/high density lipoprotein cholesterol (HDL-C) ratio (MHR) and the severity of coronary atherosclerosis, as assessed by the SYNTAX score (SXscore), in patients with stable coronary artery disease (CAD) undergoing coronary angiography.

Materials and methods: A total of 428 patients were included in the study between March 2012 and February 2015. The SXscore was determined with baseline coronary angiography. An SXscore ≥ 23 was regarded as severe CAD by definition, and the patients were divided into two groups: those with low SXscores (< 23) and those with high SXscores (≥ 23).

Results: MHR and C-reactive protein (CRP) were significantly higher in patients with high SXscores (p < 0.001 and p < 0.001, respectively). Left ventricular ejection fraction (LVEF) was lower in the group with high MHR and high SXscores. The cutoff value of MHR that predicted a high SXscore was 24, with a sensitivity of 66 % and a specificity of 65.1 %.

Conclusion: To the best of our knowledge, this is the first study in the literature showing that MHR is significantly associated with SXscores. Our results suggest that MHR can be used as a prognostic marker in patients with stable CAD, since it is an easily available and inexpensive test.

Keywords: Atherogenesis; Cholesterol; Echocardiography; Inflammation; Plaque, atherosclerotic.

Publication types

  • Comparative Study
  • Evaluation Study

MeSH terms

  • Angina, Stable / blood
  • Angina, Stable / diagnosis
  • Angina, Stable / pathology
  • Biomarkers / blood
  • Cholesterol, HDL / blood*
  • Coronary Artery Disease / blood*
  • Coronary Artery Disease / diagnosis*
  • Coronary Artery Disease / pathology
  • Female
  • Humans
  • Leukocyte Count / statistics & numerical data
  • Male
  • Middle Aged
  • Monocytes / pathology*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Severity of Illness Index*

Substances

  • Biomarkers
  • Cholesterol, HDL